BioSpace News Archive

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that the company will report its financial results for the second quarter ended June 30, 2021 after the market closes on August 4, 2021.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, announces that it has reached 70% of its enrollment target for its Phase 2 clinical study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough.

Adagene Inc. today announced that its board of directors has authorized a share repurchase program under which, Adagene may repurchase up to US$20 million of its ordinary shares in the form of American depositary shares.

Braxia Scientific Corp. is pleased to announce its participation at the upcoming Academic Industry Meeting Day (AIMday) on “Experimental Medicine in Psychiatry,” hosted by Oxford University on Wednesday, July 7, 2021.

Protara Therapeutics, Inc. today announced that management will present at the Ladenburg Thalmann Healthcare Conference being held in a virtual setting on Wednesday, July 14, 2021 at 10:00am ET.

Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has signed an exclusive worldwide licensing agreement with Altesa Biosciences, Inc. to allow Altesa to develop and commercialize Vaxart’s patented formulation of the capsid-binding VapendavirTM, a clinical-stage broad spectrum antiviral.

Ovid Therapeutics Inc. today announced that management will present in a virtual format at the Ladenburg Thalmann 2021 Healthcare Conference on Wednesday, July 14, 2021 at 9:30 a.m. ET.

AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its FAST-FIX FLEX Meniscal Repair System, the only device to offer a surgeon-guided, bendable needle and shaft providing access to all zones of the meniscus.

Drug delivery systems are becoming progressively sophisticated as pharmaceutical researchers obtain a good understanding of the biochemical and physiological parameters pertinent to their performance.